TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Octapharma Nordic AB
Closing information (x1000 EUR)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
3,265,829
|
2,852,337
|
2,515,734 |
Financial expenses |
1,824
|
3,361
|
21,263 |
Earnings before taxes |
440,238
|
511,580
|
473,177 |
EBITDA |
580,978
|
651,171
|
635,335 |
Total assets |
4,432,764
|
4,233,220
|
3,882,799 |
Current assets |
3,278,384
|
3,027,669
|
2,720,983 |
Current liabilities |
415,632
|
398,994
|
391,765 |
Equity capital |
3,830,665
|
3,619,099
|
3,299,092 |
- share capital |
120
![]() |
120
![]() |
120 |
Employees (average) |
10,587
|
9,734
|
8,336 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
86.4%
|
85.5%
|
85.0% |
Turnover per employee |
308
|
293
|
302 |
Profit as a percentage of turnover |
13.5%
|
17.9%
|
18.8% |
Return on assets (ROA) |
10.0%
|
12.2%
|
12.7% |
Current ratio |
788.8%
|
758.8%
|
694.5% |
Return on equity (ROE) |
11.5%
|
14.1%
|
14.3% |
Change turnover |
405,189
|
540,379
|
167,509 |
Change turnover % |
14%
|
23%
|
7% |
Chg. No. of employees |
853
|
1,398
|
195 |
Chg. No. of employees % |
9%
|
17%
|
2% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.